BusinessAgile Therapeutics Announces Positive Top-line Phase 3 ResultsBy Nasdaq OMXJan 3, 2017, 9:11 PM UTC
BusinessAgile Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare ConferenceBy Nasdaq OMXDec 22, 2016, 12:30 PM UTC
BusinessAgile Therapeutics Receives Approximately $3 Million in Non-Dilutive Funding from New Jersey’s Technology Business Tax Certificate Transfer ProgramBy Nasdaq OMXDec 1, 2016, 1:00 PM UTC
BusinessAgile Therapeutics to Present at the 28th Annual ROTH ConferenceBy Nasdaq OMXMar 3, 2016, 9:15 PM UTC
